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nate beads. Sulfate incorporation was measured over the final 4 
hours of culture at day 10 or 21 day for explants. 
Results: bFGF added to any of the culture conditions did not 
alter cell survival, bFGF in alginate cultures resulted in the for- 
mation of cell clusters that lacked a visible pericellular matrix and 
the addition of bFGF to IGF+OP-1 treated cultures was seen to 
inhibit the ability of the latter growth factors to stimulate pericel- 
lular matrix formation. Chondrocyte proliferation was stimulated 
at doses above lng/ml of bFGF with a maximal 2-fold increase 
at100 ng/ml. However, the 1 ng/ml dose of bFGF was sufficient o 
stimulate proliferation when combined with IGF-I or with IGF+OP- 
1, the latter resulting in the greatest stimulation of proliferation 
which was over 3.5-fold of control. The increase in cell num- 
bers correlated with a decrease in total proteoglycan (PG) lev- 
els accumulated per cell (DMB/DNA) which was 40% of control 
at 100ng/ml bFGE Although IGF-I, OP-1, or IGF-I+OP-1 signif- 
icantly increased proteoglycan levels above controls, the addi- 
tion of bFGF to these cultures resulted in significant inhibition 
of proteoglycan synthesis below levels of untreated control (45% 
of control with IGF-I+bFGF vs 128% of control with IGF-I alone; 
55% of control with OP-I+bFGF vs 186% of control with OP-1 
alone and 40% of control for bFGF+IGF-I+OP-1 vs 165% of con- 
trol with IGF-I+OP-1). Likewise, sulfate incorporation (as a mea- 
sure of new PG synthesis) in response to IGF-I and OP-1 alone 
or together was completely inhibited by 50ng/ml bFGE Similar 
effects on proteoglycan synthesis were obtained in cartilage ex- 
plants where 50ng/ml bFGF totally inhibited the ability of IGF-I or 
OP-1, alone or together, to stimulate sulfate incorporation. 
Conclusion: In adult human articular cartilage, bFGF stimulates 
proliferation at doses above lng/ml and significantly inhibits the 
anabolic activity of IGF-I and OP-1. The results suggest that ex- 
cessive release of bFGF from the cartilage matrix during injury, 
with loading, or in arthritis could contribute to reduced anabolic 
activity in cartilage. 
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Purpose: Expression of PGE2 depends upon simultaneous ex- 
pression of a cyclooxygenase (COX-l, or COX-2) and an asso- 
ciated terminal PGE synthase (PGES), in order to convert the 
COX product PGH2 into PGE2. We examined the expression 
and subcellular localization of COX-l, COX-2, microsomal PGES 
(mPGES, inducible, presumed to associate with COX-2) and cy- 
tosolic PGES (cPGES, presumed to associate with COX-l), in 
chondrocytes (C2812 cell line kindly provided by Mary Goldring) 
stimulated with IL-1. 
Methods: C2812 cells were stimulated (various times) with IL- 
1beta (10ng/ml). Lysates were analyzed for COX-l, COX-2, 
cPGES and mPGES protein and mRNA. Cells fractionated into 
nuclear and cytoplasmic components were analyzed for COXs 
and PGESs by western blot. Supernatants were analyzed for 
PGE2. 
Results: mRNA and protein for both COX-1 and cPGES were 
present in unstimulated C2812 chondrocytes; COX-1 and cPGES 
mRNA and protein levels did not change substantially with IL-1 
stimulation over a period of 24 h. In contrast, mRNA and pro- 
tein for both COX-2 and mPGES were not expressed in unstim- 
ulated C2812 cells, but were upregulated by IL-1. COX-2 protein 
was observed as early as 4 h after stimulation, reaching maxi- 
mal levels shortly thereafter, mPGES protein expression was ob- 
served somewhat later, with a peak at 24 h. Subcellular fraction- 
ation revealed that COX-1 was localized primarily to the nucleus 
(nuclear membrane), with unchanged distribution in response to 
IL-1. COX-2 and mPGES also were localized to the nucleus, but 
only after IL-1-induced expression. In contrast, cPGES was local- 
ized primarily to the cytosol, with little or no cPGES in the nuclear 
fraction of unstimulated cells. Upon IL-1 stimulation, the amount 
of cPGES at the nuclear membrane rapidly and transiently in- 
creased (maximum 236% of unstimulated at 30 min, return to 
baseline by 4 h), indicating early translocation of a portion of 
cPGES to the nucleus, and suggesting a possible COX-1/mPGES 
assemblage. Measurement of extracellular PGE2 in response to 
IL-1 revealed three phases: an early accumulation (peak 30 min; 
146% of unstimulated control) presumably related to assembly of 
the COX-1/cPGES system, a plateau phase (126% of control at 
2 h), and a late phase of production (1645% of control at 24 h), 
presumably related to a COX-2/mPGES system. 
Conclusion: Our data suggest that, in response to IL-1, PGE2 
production may occur through sequential generation and/or as- 
sembly of two sets of PGE2-producing systems: an early sys- 
tem composed of constitutively expressed COX-1/cPGES, requir- 
ing translocation of cPGES to the nuclear membrane where a 
PGE synthetic complex may be assembled, and a later, COX- 
2/mPGES system that depends on stimulated, nuclear mem- 
brane expression of both of these proteins. 
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Purpose: Cartilage degradation is a hallmark in osteoarthritis 
(OA) and loss of estrogen has been shown to be associated with 
increased prevalence of OA in postmenopausal women. It re- 
mains to be elucidated whether this potential chondroprotective 
effect of estrogen is mediated directly or indirectly on chondro- 
cytes. 
We investigated i) the effect of estrogen treatment or prevention 
on cartilage health in the rat OVX model and ii) the direct effects 
of estrogen on cartilage turnover in an cartilage explant model. 
Materials and methods: In vivo, forty 7-month old Sprague- 
Dawley rats were divided into four groups. One group was sub- 
jected to sham operation, whereas the others to OVX, followed by 
treatment with either vehicle alone, 17-b-estradiol [0.25mg/pellet 
s.c.] initiated instantly or 3 weeks after surgery and continued 
until termination after 9 weeks. Cartilage erosion was evaluated 
histologically by assessment of proteoglycan staining followed by 
microscopic measurement of eroded surface length in the articu- 
lar cartilage. Ex vivo, for articular cartilage explants culture, 144-2 
mg cartilage was isolated from bovine heifer stifle joints, and cul- 
tured in 96-well plates. Cartilage degradation was induced by on- 
costatin M (OSM) [10 ng/mL] and TNF-~ [20 ng/mL], in the pres- 
ence or absence of 17-1~-estradiol [0.1 nM - 1 I~M]. In both the 
in vivo and ex vivo settings, cartilage degradation was estimated 
by measuring the concentration of the C-telopeptide fragments 
of collagen type II (CTX-II) in serum and conditioned medium, 
respectively. 
Results: Ovariectomy induced a 66% increase in serum CTX- 
II levels compared with sham-operated animals (P<0.001), indi- 
cating an increase in cartilage degradation. In accordance with 
the accelerated collagen degradation, there was a 53% increase 
in the extent of cartilage erosion compared to sham-operated 
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animals (p<0.05). Estrogen treatment effectively prevented the 
early rise in CTX II levels as well as the development of carti- 
lage erosion at Week 9 (p<0.05). In contrast, estrogen replace- 
ment initiated 3 weeks after ovariectomy exerted similar effects 
on CTX II levels, but achived only a partial prevention of cartilage 
erosions. Under ex vivo conditions, exposure of articular carti- 
lage explants to OSM and TNF-o~ induced a 200-fold increase 
in CTX-II release (at Day 13) compared to unstimulated control 
explants. The increase in collagen type II degradation could be 
effectively and dose-dependently countered by co-administration 
of 171~-estradiol. 
Conclusion: Estrogen therapy initiated in the early phase of the 
menopause provides an effective prevention of the acceleration of 
cartilage degradation and related cartilage damage in OVX rats. 
Results of the ex vivo experiments uggest that part of the chon- 
droprotective ffects exerted by estrogen represent direct effects 
on chrondrocytes. These results warrant further investigation of 
the chondroprotective effect of estrogen and estrogen-like sub- 
stances such as SERMs. 
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Background: Death of chondrocyte cells by apoptosis is a hall- 
mark of degenerative joint diseases such as osteoarthritis (OA). 
Combination of Tumour Necrosis Factor o~ (TNF-o 0 and Actino- 
mycin D (ActD) or TNF-o~ and Ro 31-8220 have been proved to in- 
duce apoptosis in chondrocytes. Both ActD and Ro 31-8220 are, 
although much more specific the second one, inhibitors of Mito- 
gen Kinase Phosphatase 1 (MKP-1) expresion. Tumour Growth 
Factor I~-1 (TGF-I~I) is a multifunctional citoquine that provides 
signals for both cell survival and apoptosis, the final output de- 
pending on cell type and cellular context. 
Objectives: In this work, we studied if TGF-I~I is able to protect 
human chondrocytes from apoptosis induced by two in vitro mod- 
els which use inhibition of MKP-1 as one of their major target: 
TNF-o~ +ActD and TNF-o~ + Ro31-8220. Furthermore, we asses 
the effect of TGF- I~1 on mitochondrial activity. 
Methods: Human OA cartilage was obtained from the femoral 
heads of 8 patients who were undergoing joint replacement 
surgery. Cell viability was asessed by MTT assay, apoptosis by 
flow cytometry (propidium iodide) and ELISA cell death and nu- 
clear morphological cell analysis by DAPI. To determine intra- 
cellular ATP levels, a luminescence ATP detection assay system 
based on the production of light caused by the reaction of ATP 
with added luciferase and D-luciferin was employed. 
Results: It was established two groups of cells; only one of 
them was preincubated for 120h with TGF-I~I. Afterwards, both 
groups were stimulated with TNF- o~ and ActD or TNF- o~ and 
Ro 31-8220 for 16h. The viability (Basal 100%) decrease sig- 
nificantly in the non TGF-I~I preincubated group (TNF-o~+ActD 
71.0% vs TGF-I~I + TNF-o~+ActD 86.7%, p< 0.05; TNF-o~+Ro 31- 
8220 67.0% vs TGF-I~I + TNF-o~+ActD 86.9%, p<0.05). Moreover, 
TGF-I~I significantly reduced the percentage of hypodiploid chon- 
drocytes (TN F-o~+ActD 15.9% vs TGF-I~I + TNF-o~+ActD 9.5%, p< 
0.01; TNF-o~+Ro 31-8220 13.0% vs TGF-I~I + TNF-o~+Ro 31-8220 
5.7%, p< 0.05), just as the percentage of internucleosomal DNA 
breakage (TNF-o~+ActD 100% vs TGF-I~I+ TNF-o~+ActD 70.5%, 
p< 0.05), induced by MKP-1 inhibition. Furthermore, morpholog- 
ical analysis by DAPI fits well with previous results. Finally, to ex- 
amine the role of mitochondria in the protection by TGF-I~I, we 
studied the effect on ATP synthesis, proving an exponential in- 
crease along the time (96h data; TGF-I~I 289.8% vs Basal 100%, 
p<0.01). 
Conclusion: These results show that TGF-I~I is able to partially 
blocks the apoptosis induced by TNF-o~+ActD and TNF-o~+Ro 31 - 
8220, which give insights into a probable protector ole through 
the modulation of the MKP-1 activity. Furthermore, mitochondrial 
activity also seems to have a major role in this protection. 
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Aim: Degeneration and the loss of extracellular matrix macro- 
molecules from cartilage result in serious impairment of joint 
function. To determine how the extracellular matrix protein 
matrilin-2 is degraded in cartilage, we identified the extracellu- 
lar proteinase that cleaves matrilin-2, and the pro-inflammatory 
conditions under which matrilin-2 is cleaved. 
Method: Recombinant matrilin-2 protein was generated from ex- 
pression in mammalian cells of a matrilin-2 cDNA cloned from 
mouse cartilage. Three matrilin-2 deletion cDNA constructs were 
generated by overlapping PCR. These constructs were trans- 
fected into COS-1 cells, and conditioned medium was collected. 
Human articular chondrocytes were incubated with the condi- 
tioned medium containing matrilin-2 in the presence of 10ng/ml 
IL-la or 10ng/ml TGF-b. Furthermore, matrilin-2 recombinant 
protein was purified from conditioned medium and incubated with 
recombinant ADAMTS4. Matrilin-2 cleavage products were iden- 
tified by western blot analysis and SELDI mass spectrometry. 
Result: We affinity-purified the recombinant matrilin-2 protein 
from the conditioned medium of COS-1 cells transfected with 
matrilin-2 cDNA. We found that purified matrilin-2 was cleaved 
by ADAMTS4 after incubation at 37C for 24hours. A 39 KD N- 
terminal cleavage product and a 23 KD C-terminal matrilin cleav- 
age product was identified by both SELDI mass spectrometry 
and western blot analysis. Thus, purified recombinant MATN2 
that is free from GAGs or any other proteoglycans can be 
cleaved by ADAMTS4. To localize the ADAMTS4 cleavage site 
within matrilin-2, we incubated truncated MATN2 recombinant 
protein with ADAMTS4. Partial truncation of the unique domain of 
matrilin-2 reduced the cleavage, and deletion of the whole unique 
domain eliminated the cleavage by ADAMTS4. Thus, the unique 
domain of matrilin-2 was essential for ADAMTS4 proteolysis. To 
determine whether proteolysis of matrilin-2 in cartilage is de- 
pendent on growth factors that exert pro-inflammatory esponse, 
primary human articular chondrocytes were incubated with the 
medium containing matrilin-2 either in the presence or absence 
of TGF-b and IL-la. Treatment of chondrocytes with either TGF- 
b or IL-la significantly stimulates the proteolysis of matrilin-2 by 
ADAMTS4. This indicates that proteolysis of matrilin-2 in cartilage 
is dependent on the presence of TGF-b or IL-la. 
Summary: Our study demonstrated for the first time that 
ADAMTS4 (aggrecanase-1) is capable of cleaving matrilin-2, a 
non-proteoglycan matrix protein in a GAG independent manner. 
Our data further suggest that ADAMTS4 cleavage of matrilin- 
2 occurs in the unique domain, and is stimulated under pro- 
inflammatory conditions including IL-la. This cleavage will re- 
lease the matrix-binding vWF A domain of matrilin-2 from the car- 
tilage extracellular matrix, thereby contributing to the breakdown 
of matrilin network and cartilage degeneration during arthritis. 
